NAOMI F. ROTHFIELD, M.D.
This content is PDF only. Please click on the PDF icon to access.
The use of immunosuppressive therapy in patients with systemic lupus erythematosus has become widespread during the past few years because of a number of reports describing its efficacy. These reports suggest that the use of cytotoxic drugs with corticosteroids leads to a more favorable outcome than treatment with corticosteroids alone. The enthusiastic use of several of these agents is now common and is not always reserved for those patients with life-threatening disease. Most of the literature upon which such enthusiasm is based consists of case reports or uncontrolled trials. Other studies have compared a group of patients recently treated with
ROTHFIELD NF. Immunosuppressive Therapy in Lupus Erythematosus. Ann Intern Med. ;83:727–728. doi: 10.7326/0003-4819-83-5-727
Download citation file:
Published: Ann Intern Med. 1975;83(5):727-728.
Lupus Erythematosus, Rheumatology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use